The Latest Breaking News from FDA

Some studies link the popular soda sweetener to higher cancer risk, but the links are weak and questions remain

MindMed is a high-flying pre-revenue company that has more than doubled investor returns in the last 12 months.

The healthcare sector is expected to grow rapidly due to the growing need for precision drugs, the rising elderly population, government initiatives, and increasing chronic diseases. Against this backdrop, investors could consider buying fundamentally strong, undervalued healthcare stocks such as AbbVie (ABBV), Bristol-Myers Squibb (BMY), and Gilead Sciences (GILD). Read…

FDA and Justice Department join forces to crack down on illegal e-cigarette sales in the U.S., targeting unauthorized vaping products and manufacturers.

The drug is already approved for limited use in Australia to treat PTSD and depression.

FDA has issued a warning after six people were hospitalized across four states following the consumption of Diamond Shruumz-brand's microdosing chocolate bars.

The U.S. Food and Drug Administration says consumers should avoid eating shellfish from Oregon and Washington state as they may be contaminated with toxins that cause paralytic shellfish poisoning

Federal health advisers have endorsed a closely watched Alzheimer’s drug from Eli Lilly for people with mild dementia

Federal health regulators and law enforcement officials are vowing to work more closely to stop sales of illegal electronic cigarettes, including those from China